Leadinno Medical Valley Raises RMB 100M in Series A Financing for Neuromodulation Devices
Beijing-based neuromodulation medical device maker Leadinno Medical Valley reportedly raised over RMB 100 million (USD...
Transcenta’s TST001 Shows Promise in Gastric Cancer Trial with 73.3% Response Rate
China-based biotech Transcenta Holdings Ltd (HKG: 6628) announced interim safety and efficacy data from a...
CSPC Pharmaceutical’s TG103 Gains NMPA Approval for NASH and Alzheimer’s Trials
China-based CSPC Pharmaceutical Group Co., Ltd (HKG: 1093) announced that it has received approval from...
Jingxin Pharmaceutical Receives NMPA Approval for JBPOS0101 and JX7002 Trials
Jingxin Pharmaceutical Co., Ltd (SHE: 002020) announced that it has received clinical trial approvals from...
China’s Retail Pharmacy O2O Sales Surge to USD 2.9B in 2021
According to the “China Retail Pharmacy O2O Development Report” released by Minenet, the “online drug...
National High-Value Medical Consumables VBP Round Targets Orthopedic Spine Products
The national high-value medical consumables joint procurement office released a set of guiding opinions on...
China’s Cecolin HPV Vaccine Shows 100% Efficacy in 66-Month Study
Chinese researchers have published 66-month follow-up data from a Phase III clinical study for the...
Dizal Pharma’s Sunvozertinib Gains NMPA Approval for EGFR Mutation NSCLC Trial
China-based Dizal Pharmaceutical Co., Ltd (SHA: 688192) announced that it has received clinical trial approval...
MofCOM’s 2021 Pharma Distribution Report Shows Market Recovery
The Ministry of Commerce (MofCOM) released its annual statistical review of the pharma distribution industry...
NHSA Issues Notice on Special Treatment of Oral Implant Medical Service Charges
The National Healthcare Security Administration (NHSA) has released a Notice on “Carrying out Special Treatment...
Keymed and Lepu’s CMG901 Receives Breakthrough Therapy Designation for Gastric Cancer
The Center for Drug Evaluation (CDE) website indicates that CMG901, a Claudin 18.2 (CLDN18.2)-targeted antibody...
Realcan Pharma and AWS Expand Partnership for Digital Transformation
China-based Realcan Pharmaceutical Group Co., Ltd (SHE: 002589) and Amazon Web Services (AWS) have agreed...
Salipro Biotech Secures Patent Protection for Membrane Protein Stabilization Tech
Sweden-based Salipro Biotech AB announced that its core technology for stabilizing membrane proteins for drug...
Sirnaomics Initiates Phase I Study of STP705 for Abdominal Fat Reduction
Sino-US siRNA therapy developer Sirnaomics Ltd (HKG: 2257) has announced the first subject dosing in...
China Pharma H1 2022 Financials: 40% of Firms Report Revenue and Profit Growth
A total of 449 pharmaceutical and health-tech companies listed in China have released their H1...
Suzhou InnoBM Pharmaceuticals Raises Series A+ Funding for Tumor Immunotherapy
China-based Suzhou InnoBM Pharmaceuticals reportedly raised tens of millions of renminbi in a Series A+...
Laekna Therapeutics Doses First Patient in LAE001/LAE002 Study for Prostate Cancer
China-based Laekna Therapeutics Shanghai Co., Ltd announced that the first patient has been dosed in...
NHSA Reveals Drugs Passing Initial Review for NRDL Inclusion
The National Healthcare Security Administration (NHSA) released a notification listing the drugs that have passed...
Innovent’s Tyvyt Combo Shows PFS Benefit in EGFR-Mutant NSCLC
China-based Innovent Biologics Inc. (HKG: 1801) announced positive results from the Phase III ORIENT-31 study...
Huadong Medicine Pays EUR 105M for 35% Stake in Heidelberg Pharma
China’s Huadong Medicine Co., Ltd (SHE: 000963) announced that it has paid a total of...